Vasundhara Rasayans
172.90
-4.00(-2.26%)
Market Cap₹54.93 Cr
PE Ratio9.71
IndustryHealthcare
Company Performance:
1D-2.26%
1M+2.25%
6M+20.24%
1Y-14.83%
5Y+53.62%
View Company Insightsright
More news about Vasundhara Rasayans
10Feb 26
Vasundhara Rasayans Reports 50.4% Decline in Q3FY26 Net Profit to ₹72.05 Lakhs
Vasundhara Rasayans Ltd reported challenging Q3FY26 results with net profit declining 50.4% to ₹72.05 lakhs from ₹145.28 lakhs in Q3FY25. Revenue from operations fell 15.6% to ₹744.77 lakhs, while total expenses decreased to ₹714.39 lakhs. For nine months FY26, net profit dropped 13.1% to ₹335.05 lakhs with revenue declining 9.2% to ₹2,382.99 lakhs. EPS for the quarter stood at ₹2.27 compared to ₹4.57 in the previous year.
 no imag found
06Sept 25
Vasundhara Rasayans Declares Rs. 2 Per Share Dividend, Appoints New Directors
Vasundhara Rasayans Limited has announced a dividend of Rs. 2.00 per equity share. The company appointed Shri Ashok Kumar Jain as Additional Independent Director and Shri Kodakandla Sidarsanam as additional Whole-time Director. The 37th Annual General Meeting (AGM) is scheduled with book closure from September 24-30 and a cut-off date of September 23 for e-voting and dividend eligibility. Mrs. Rakhi Agarwal has been appointed as the e-voting Scrutinizer for the AGM.
 no imag found
13Aug 25
Vasundhara Rasayans Reports Q1 Net Profit of ₹57.28 Crore, Down 33.5% Year-on-Year
Vasundhara Rasayans Limited announced Q1 financial results, showing a 2.08% increase in total income to ₹824.50 lakh, but a 33.51% decrease in net profit to ₹57.28 lakh. Net sales slightly decreased by 0.90% to ₹756.15 lakh. Total expenses rose by 8.08% to ₹747.10 lakh, primarily due to increased finance costs and other expenses. Earnings per share dropped from ₹2.71 to ₹1.80. The company operates in the agri products segment.
 no imag found
Vasundhara Rasayans
172.90
-4.00
(-2.26%)
1 Year Returns:-14.83%
Industry Peers
Sun Pharmaceutical
1,963.50
(-1.36%)
Divis Laboratories
8,585.00
(+6.57%)
Torrent Pharmaceuticals
5,050.00
(-1.42%)
Cipla
1,474.40
(+0.08%)
Zydus Life Science
1,121.00
(-0.51%)
Lupin
2,393.00
(-0.91%)
Mankind Pharma
2,483.00
(+0.54%)
Dr Reddys Laboratories
1,180.00
(+2.78%)
Laurus Labs
1,811.40
(-0.26%)
Aurobindo Pharma
1,554.70
(-1.61%)